Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C12H16N6S |
| Molecular Weight | 276.361 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 1 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CC1=C(CSCCNC(NCC#C)=NC#N)N=CN1
InChI
InChIKey=KEDVUOWPLAHMLZ-UHFFFAOYSA-N
InChI=1S/C12H16N6S/c1-3-4-14-12(16-8-13)15-5-6-19-7-11-10(2)17-9-18-11/h1,9H,4-7H2,2H3,(H,17,18)(H2,14,15,16)
| Molecular Formula | C12H16N6S |
| Molecular Weight | 276.361 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 1 |
| Optical Activity | NONE |
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| Pharmacological profile of etintidine, a new histamine H2-receptor antagonist. | 1986-05 |
|
| In vitro and in vivo comparisons of antiandrogenic potencies of two histamine H2-receptor antagonists, cimetidine and etintidine--HCl. | 1985-06 |
|
| A comparison of some of the pharmacological properties of etintidine, a new histamine H2-receptor antagonist, with those of cimetidine, ranitidine and tiotidine. | 1983-01 |
|
| Clinical pharmacology of etintidine in patients with duodenal ulcer. | 1982 |
Patents
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/6130952
100 or 300 mg
Route of Administration:
Oral
| Substance Class |
Chemical
Created
by
admin
on
Edited
Wed Apr 02 07:52:39 GMT 2025
by
admin
on
Wed Apr 02 07:52:39 GMT 2025
|
| Record UNII |
A60Z457SSF
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Official Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C29702
Created by
admin on Wed Apr 02 07:52:39 GMT 2025 , Edited by admin on Wed Apr 02 07:52:39 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
135413503
Created by
admin on Wed Apr 02 07:52:39 GMT 2025 , Edited by admin on Wed Apr 02 07:52:39 GMT 2025
|
PRIMARY | |||
|
100000082096
Created by
admin on Wed Apr 02 07:52:39 GMT 2025 , Edited by admin on Wed Apr 02 07:52:39 GMT 2025
|
PRIMARY | |||
|
CHEMBL2110898
Created by
admin on Wed Apr 02 07:52:39 GMT 2025 , Edited by admin on Wed Apr 02 07:52:39 GMT 2025
|
PRIMARY | |||
|
274-036-2
Created by
admin on Wed Apr 02 07:52:39 GMT 2025 , Edited by admin on Wed Apr 02 07:52:39 GMT 2025
|
PRIMARY | |||
|
C036616
Created by
admin on Wed Apr 02 07:52:39 GMT 2025 , Edited by admin on Wed Apr 02 07:52:39 GMT 2025
|
PRIMARY | |||
|
DTXSID40219795
Created by
admin on Wed Apr 02 07:52:39 GMT 2025 , Edited by admin on Wed Apr 02 07:52:39 GMT 2025
|
PRIMARY | |||
|
69539-53-3
Created by
admin on Wed Apr 02 07:52:39 GMT 2025 , Edited by admin on Wed Apr 02 07:52:39 GMT 2025
|
PRIMARY | |||
|
4889
Created by
admin on Wed Apr 02 07:52:39 GMT 2025 , Edited by admin on Wed Apr 02 07:52:39 GMT 2025
|
PRIMARY | |||
|
SUB07305MIG
Created by
admin on Wed Apr 02 07:52:39 GMT 2025 , Edited by admin on Wed Apr 02 07:52:39 GMT 2025
|
PRIMARY | |||
|
A60Z457SSF
Created by
admin on Wed Apr 02 07:52:39 GMT 2025 , Edited by admin on Wed Apr 02 07:52:39 GMT 2025
|
PRIMARY | |||
|
C81154
Created by
admin on Wed Apr 02 07:52:39 GMT 2025 , Edited by admin on Wed Apr 02 07:52:39 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
SALT/SOLVATE -> PARENT |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |